1. |
Pickkers P, Vassiliou T, Liguts V, et al. Sepsis management with a blood purification membrane: European experience. Blood Purif, 2019, 47(Suppl 3): 1-9.
|
2. |
Zhang L, Cove M, Nguyen BG, et al. Adsorptive hemofiltration for sepsis management: expert recommendations based on the Asia Pacific experience. Chin Med J (Engl), 2021, 134(18): 2258-2260.
|
3. |
Sakr Y, Jaschinski U, Wittebole X, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis, 2018, 5(12): ofy313.
|
4. |
Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med, 2007, 35(10): 2408-2416.
|
5. |
Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med, 2013, 39(9): 1535-1546.
|
6. |
Atan R, Peck L, Prowle J, et al. A double-blind randomized controlled trial of high cutoff versus standard hemofiltration in critically ill patients with acute kidney injury. Crit Care Med, 2018, 46(10): e988-e994.
|
7. |
Marshall JC. Endotoxin in the pathogenesis of sepsis. Contrib Nephrol, 2010, 167: 1-13.
|
8. |
Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs, 2003, 27(9): 792-801.
|
9. |
Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J, 2013, 59(2): 99-106.
|
10. |
Guan M, Wang H, Tang X, et al. Continuous renal replacement therapy with adsorbing filter oxiris in acute kidney injury with septic shock: a retrospective observational study. Front Med (Lausanne), 2022, 9: 789623.
|
11. |
Romaschin AD, Klein DJ, Marshall JC. Bench-to-bedside review: clinical experience with the endotoxin activity assay. Crit Care, 2012, 16(6): 248.
|
12. |
Broman ME, Hansson F, Vincent JL, et al. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One, 2019, 14(8): e0220444.
|
13. |
Zhang H, Zhu G, Yan L, et al. The absorbing filter Oxiris in severe coronavirus disease 2019 patients: a case series. Artif Organs, 2020, 44(12): 1296-1302.
|
14. |
Schwindenhammer V, Girardot T, Chaulier K, et al. oXiris® use in septic shock: experience of two french centres. Blood Purif, 2019, 47(Suppl 3): 1-7.
|
15. |
Shum HP, Chan KC, Kwan MC, et al. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J, 2013, 19(6): 491-497.
|
16. |
Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care, 2013, 17(1): 204.
|
17. |
中华医学会肾脏病学分会, 中国研究型医院学会肾脏病学专业委员会. 特殊血液净化技术应用于重症新型冠状病毒肺炎的专家共识. 中华内科杂志, 2020, 59(11): 847-853.
|
18. |
Marshall JC, Walker PM, Foster DM, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care, 2002, 6(4): 342-348.
|